MEDINCELL - Weekly - Technical analysis published on 05/20/2024 (GMT)
- 69
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Weekly
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
78%
6%
17%
My opinion
Bullish above 12.67 EUR
My targets
16.15 EUR (+13.10%)
My analysis
MEDINCELL is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 12.67 EUR. The next resistance located at 16.15 EUR is the next bullish objective to be reached. A bullish break in this resistance would boost the bullish momentum. With the current pattern, you will need to monitor for possible bullish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bullish trend. Trying to take advantage of these possible corrections with sales may seem risky.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8.4
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by pierrott. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
MEDINCELL rating 14.28 EUR. Over 5 days, this instrument lost -4.80% with the lowest point at 13.42 EUR and the highest point at 14.58 EUR. The deviation from the price is +6.41% for the low point and -2.06% for the high point.13.42
14.58
14.28
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
A technical analysis in Weekly of this MEDINCELL chart shows a strongly bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
In fact, according to the parameters integrated into the Central Analyzer system, 14 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 80
Type : Neutral
Timeframe : Weekly
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Weekly
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : Weekly
RSI indicator: bearish divergence
Type : Bearish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
Price
S3 | S2 | S1 | Price | R1 | |
---|---|---|---|---|---|
ProTrendLines | 7.33 | 8.74 | 10.14 | 14.28 | 16.15 |
Change (%) | -48.67% | -38.80% | -28.99% | - | +13.10% |
Change | -6.95 | -5.54 | -4.14 | - | +1.87 |
Level | Intermediate | Intermediate | Major | - | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 13.10 | 13.32 | 13.76 | 13.98 | 14.42 | 14.64 | 15.08 |
Camarilla | 14.02 | 14.08 | 14.14 | 14.20 | 14.26 | 14.32 | 14.38 |
Woodie | 13.21 | 13.38 | 13.87 | 14.04 | 14.53 | 14.70 | 15.19 |
Fibonacci | 13.32 | 13.57 | 13.73 | 13.98 | 14.23 | 14.39 | 14.64 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 11.27 | 12.35 | 13.27 | 14.35 | 15.27 | 16.35 | 17.27 |
Camarilla | 13.65 | 13.83 | 14.02 | 14.20 | 14.38 | 14.57 | 14.75 |
Woodie | 11.20 | 12.31 | 13.20 | 14.31 | 15.20 | 16.31 | 17.20 |
Fibonacci | 12.35 | 13.11 | 13.58 | 14.35 | 15.11 | 15.58 | 16.35 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 5.19 | 7.12 | 10.74 | 12.67 | 16.29 | 18.22 | 21.84 |
Camarilla | 12.83 | 13.34 | 13.85 | 14.36 | 14.87 | 15.38 | 15.89 |
Woodie | 6.04 | 7.54 | 11.59 | 13.09 | 17.14 | 18.64 | 22.69 |
Fibonacci | 7.12 | 9.24 | 10.55 | 12.67 | 14.79 | 16.10 | 18.22 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
RSI (14): | 81.25 | |
MACD (12,26,9): | 1.7100 | |
Directional Movement: | 43.01 | |
AROON (14): | 85.72 | |
DEMA (21): | 12.47 | |
Parabolic SAR (0,02-0,02-0,2): | 10.05 | |
Elder Ray (13): | 2.97 | |
Super Trend (3,10): | 12.21 | |
Zig ZAG (10): | 14.20 | |
VORTEX (21): | 1.3100 | |
Stochastique (14,3,5): | 74.88 | |
TEMA (21): | 13.65 | |
Williams %R (14): | -36.87 | |
Chande Momentum Oscillator (20): | 5.21 | |
Repulse (5,40,3): | 3.7600 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 2.1100 | |
Courbe Coppock: | 99.55 |
MA7: | 14.54 | |
MA20: | 13.79 | |
MA50: | 11.25 | |
MA100: | 9.79 | |
MAexp7: | 12.76 | |
MAexp20: | 10.49 | |
MAexp50: | 8.76 | |
MAexp100: | 8.06 | |
Price / MA7: | -1.79% | |
Price / MA20: | +3.55% | |
Price / MA50: | +26.93% | |
Price / MA100: | +45.86% | |
Price / MAexp7: | +11.91% | |
Price / MAexp20: | +36.13% | |
Price / MAexp50: | +63.01% | |
Price / MAexp100: | +77.17% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
Don't forget to follow the news on MEDINCELL. At the time of publication of this analysis, the latest news was as follows:
- MedinCell and the European Investment Bank (EIB) Have Replaced a Financial Covenant of Their Ongoing Loan Agreement to Better Fit with MedinCell Business Model
- MedinCell: Participation Terms in the Combined General Meeting
- MedinCell’s Partner Teva Announces Successful Launch of UZEDY™
- MedinCell’s Partner Teva Announces Successful Launch of UZEDY™
- MedinCell has Received the Last Tranche of €10m from the European Investment Bank (EIB) Loan
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis MEDINCELL - Weekly